The same trend was observed in studies with concomitant OA medications permitted, and overall, but this did not reach statistical significance (Fig. 5 ).
← all excerpts
Safety of Symptomatic Slow-Acting Drugs for Osteoarthritis: Outcomes of a Systematic Review and Meta-Analysis.
1
—
—